45 years and over
- 11 Dec 2023
- 1 Minute to read
- Print
- PDF
45 years and over
- Updated on 11 Dec 2023
- 1 Minute to read
- Print
- PDF
Article summary
Did you find this summary helpful?
Thank you for your feedback
The BMS says in women >45 years the diagnosis of menopause or perimenopause should be considered based on symptoms alone, without blood tests, unless there is uncertainty about the diagnosis.
NICE says identify:
- PERIMENOPAUSE if they have new onset vasomotor symptoms and any changes in their menstrual cycle.
- MENOPAUSE if they have not had a period for at least 12 months and are not using hormonal contraception OR based on the symptoms they have, in those without a uterus.
Although NICE says identify the perimenopause in women with vasomotor symptoms and a change in menstrual cycle it is important to be aware that 25% of women will not get vasomotor symptoms.
Be aware that women from ethnic minority backgrounds may experience menopause at a younger age compared with women from White backgrounds.
NOTE:
- Diagnosis can be more difficult in women using hormone treatments or in women with a prior history of endometrial ablation or hysterectomy. These women will have altered or absent bleed patterns. For more information see flowchart in: The 2023 Practitioners Toolkit for Managing Menopause on Page 7.
- If in doubt, refer to a menopause specialist.
Further Information:
- NICE Menopause: diagnosis and management. Section 1.2.1. Diagnosis of perimenopause and menopause. Last updated December 2019.
- Menopause Practice Standards produced by the British Menopause Society (BMS), Royal College of Obstetricians and Gynaecologists (RCOG), Society for Endocrinology (SfE), Faculty of Sexual and Reproductive Health (FSRH), Faculty of Pharmaceutical Medicine (FPM) and Royal Pharmaceutical Society (RPS) 2022.
- National Institute for Health and Care Excellence. Guideline. Menopause (update). Draft for consultation, Nov 2023.
- Hamoda H, Panay N, Pedder H et al. The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020.
Was this article helpful?